Innovation Hub
The latest breakthroughs, technologies, and resources across every stage in the drug development lifecycle.
Button Text







Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Chemical & Compound Analysis
Clinical Trials
No items found.

Blog
The private health insurances as the entrance into German market access - is this true, Dr. Bastian Biermann?
February 15, 2022
Read blog
Market Access
No items found.
Disease Models
No items found.
Biomarkers
Clinical Trials
HBS
BioChain

Blog
How can a company derive the optimal price for their medical product, Dr. Renato, Dellamano?
February 1, 2022
Read blog
Health Economics & Outcomes Research (HEOR)
No items found.
Biomarkers
Pharmacology
Nashville Biosciences
Biomarkers
Disease Models
No items found.
Biomarkers
DNA & RNA
No items found.
Health Economics & Outcomes Research (HEOR)
No items found.

Blog
Dr. Michael Zuercher - Commerical attractiveness of the Swiss health care market - success starts with market access.
December 1, 2021
Read blog
Market Access
No items found.
Biomarkers
Protein Sciences
Pharmacology
Chemical & Compound Analysis
Clinical Trials
Eurofins Discovery
Disease Models
Lee M. Kaplan
No items found.
American Physiological Society
The Obesity Society
Medical Communications
Michelle Gumz
Carrie Northcott
No items found.
American Physiological Society
Disease Models
Lauren Woodie
E. Matthew Morris
Sable Systems International Inc.
No items found.
Instrumentation & Products
Disease Models
Jacqueline Limberg
ADInstruments
American Physiological Society
Medical Communications
Christopher Banek
Kelly Hyndman
No items found.
American Physiological Society
Disease Models
Lior Bikovski
Shivang Sunil Parikh
Noldus Information Technology
No items found.
Chemical & Compound Analysis
Tanja Reinert
Theo Schneider
Heraeus Noblelight
No items found.
Health Economics & Outcomes Research (HEOR)
No items found.
No items found.
No items found.
Pharmacology
Disease Models
Ania Jastreboff
No items found.
American Physiological Society
The Obesity Society

Podcast
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
July 13, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)

Podcast
Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO
February 23, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)

Podcast
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
October 6, 2025
Read podcast
Health Economics & Outcomes Research (HEOR)
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.

Whitepaper
Insights from Spatial Biology in Drug Discovery at IRBM: The Impact of Cellular Ecosystems
July 28, 2026
Sponsored by:
Sponsor
Access now
Bioimaging
Biomarkers
DNA & RNA
Protein Sciences
Disease Models
IRBM

Whitepaper
Direct to Biology: An Approach to Streamline the DMTA Cycle in PROTAC Discovery
July 7, 2026
Sponsored by:
Sponsor
Access now
Protein Sciences
Pharmacology
In Vitro Assays
DMPK
Concept Life Sciences































.avif)






